AGATE, LAURA Statistiche
AGATE, LAURA
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
, Descrizione della prima mutazione omozigote germinale di RET (Ala883->Thr) che non determina l'insorgenza del carcinoma midollare della tiroide in condizioni di eterozigosi
2003-01-01 Cosci, Barbara; Romei, Cristina; Agate, Laura; Piampiani, P; Vivaldi, A; Ciampi, R; Nikiforov, Y; Pinchera, Aldo; Elisei, Rossella
5 Years Follow Up Of Thyroglobulin (Tg), Thyroglobulin Antibodies (Tgab) And Neck Ultrasound (Nus) In Patients With Papillary Thyroid Microcarcinoma (Mptc) Treated With Total Thyroidectomy But Not Ablated With 131I
2016-01-01 Matrone, Antonio; Faranda, Alessio; Molinaro, Eleonora; Agate, Laura; Viola, David; Valerio, Laura; Giani, Carlotta; Liborio, Torregrossa; Piaggi, Paolo; Vitti, Paolo; Elisei, Rossella
5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I
2015-01-01 Matrone, A.; Faranda, A.; Molinaro, E.; Agate, L.; Viola, D.; Valerio, L.; Giani, C.; Torregrossa, L.; Piaggi, P.; Vitti, P.; Elisei, R.
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion.
2019-01-01 Giani, Carlotta; Romei, Cristina; Ciampi, Raffaele; Valerio, Laura; Tacito, Alessia; Ramone, Teresa; Materazzi, Gabriele; Torregrossa, Liborio; Ugolini, Clara; Franchi, Alessandro; Basolo, Fulvio; Agate, Laura; Elisei, Rossella
A novel fusion RET/PTC3 involving NCOA4 and RET genes in a pediatric case of Papillary Thyroid Carcinoma
2015-01-01 Ciampi, Raffaele; Romei, Cristina; Tacito, Alessia; Casella, Francesca; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Matrone, Antonio; Vitti, Paolo; Elisei, Rossella
A rare adverse event (AE) in a group of radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients in therapy with lenvatinib.
2019-01-01 Puleo, Luciana; Giani, Carlotta; Valerio, Laura; Viola, David; Molinaro, Eleonora; Elisei, Rossella; Agate, Laura
Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal
2002-01-01 Pacini, F; Molinaro, Eleonora; Castagna, Mg; Lippi, F; Ceccarelli, C; Agate, Laura; Elisei, Rossella; Pinchera, Aldo
Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center
2017-01-01 Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Marcocci, Claudio; Vitti, Paolo; Elisei, Rossella; Molinaro, Eleonora
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center
2020-01-01 Molinaro, Eleonora; Campopiano, Maria Cristina; Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Cappagli, Virginia; Valerio, Laura; Giani, Carlotta; Puleo, Luciana; Lorusso, Loredana; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Tuttle, R Michael; Elisei, Rossella
Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia
2021-01-01 Prete, A.; Matrone, A.; Gambale, C.; Bottici, V.; Cappagli, V.; Romei, C.; Torregrossa, L.; Valerio, L.; Minaldi, E.; Campopiano, M. C.; Lorusso, L.; Agate, L.; Molinaro, E.; Viola, D.; Ramone, T.; Mule, C.; Ciampi, R.; Basolo, F.; Elisei, R.
Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center.
2013-01-01 D. Viola, L. Valerio; Faviana, Pinuccia; Molinaro, Eleonora; Sensi, Elisa; Agate, Laura; Materazzi, Gabriele; Basolo, Fulvio; Miccoli, Paolo; Vitti, Paolo
All-trans Retinoic Acid treatment inhibits the growth of RARb mRNA expressing thyroid cancer cell lines but does not re-induce the expression of thyroid specific genes
2004-01-01 Agate, Laura; Vivaldi, A; Ciampi, R; Molinaro, Eleonora; Pacini, F; Pinchera, Aldo; Elisei, Rossella
ALL-TRANS RETINOIC ACID TREATMENT INHIBITS THE GROWTH OF RARb mRNA EXPRESSING THYROID CANCER CELL LINES BUT DOES NOT RE-INDUCE THE EXPRESSION OF THYROID SPECIFIC GENES
2005-01-01 Elisei, Rossella; Vivaldi, A; Agate, Laura; Ciampi, R; Molinaro, Eleonora; Piampiani, P; Romei, Cristina; Faviana, Pinuccia; Basolo, Fulvio; Miccoli, Paolo; Capodanno, A; Collecchi, P; Pacini, F; Pinchera, Aldo
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
2017-01-01 Molinaro, Eleonora; Romei, Cristina; Biagini, Agnese; Sabini, Elena; Agate, Laura; Mazzeo, Salvatore; Materazzi, Gabriele; SELLARI FRANCESCHINI, Stefano; Ribechini, Alessandro; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.
2010-01-01 Elisei, Rossella; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Masserini, Lucio; Ceccarelli, C; Lippi, F; Grasso, Lucia; Basolo, Fulvio; Bevilacqua, Generoso; Miccoli, Paolo; Di Coscio, G; Vitti, Paolo; Pacini, F; Pinchera, Aldo
Assessing mPTC Progression during Active Surveillance: Volume or Diameter Increase?
2021-01-01 Campopiano, Maria Cristina; Matrone, Antonio; Rago, Teresa; Scutari, Maria; Prete, Alessandro; Agate, Laura; Piaggi, Paolo; Elisei, Rossella; Molinaro, Eleonora
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study.
2012-01-01 Viola, David; Torregrossa, L; Giannini, Riccardo; Ugolini, C; Bigini, A; Romei, C; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella
Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST
2021-01-01 Lorusso, Loredana; Romei, Cristina; Piaggi, Paolo; Fustini, Chiara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Pellegrini, Giovanni; Elisei, Rossella
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line
2012-01-01 Vivaldi, Agnese; Ciampi, Raffaele; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P.; Elisei, Rossella
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line.
2012-01-01 Vivaldi, A; Ciampi, R; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P; Elisei, Rossella
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| , Descrizione della prima mutazione omozigote germinale di RET (Ala883->Thr) che non determina l'insorgenza del carcinoma midollare della tiroide in condizioni di eterozigosi | 1-gen-2003 | Cosci, Barbara; Romei, Cristina; Agate, Laura; Piampiani, P; Vivaldi, A; Ciampi, R; Nikiforov, Y; Pinchera, Aldo; Elisei, Rossella | |
| 5 Years Follow Up Of Thyroglobulin (Tg), Thyroglobulin Antibodies (Tgab) And Neck Ultrasound (Nus) In Patients With Papillary Thyroid Microcarcinoma (Mptc) Treated With Total Thyroidectomy But Not Ablated With 131I | 1-gen-2016 | Matrone, Antonio; Faranda, Alessio; Molinaro, Eleonora; Agate, Laura; Viola, David; Valerio, Laura; Giani, Carlotta; Liborio, Torregrossa; Piaggi, Paolo; Vitti, Paolo; Elisei, Rossella | |
| 5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I | 1-gen-2015 | Matrone, A.; Faranda, A.; Molinaro, E.; Agate, L.; Viola, D.; Valerio, L.; Giani, C.; Torregrossa, L.; Piaggi, P.; Vitti, P.; Elisei, R. | |
| A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. | 1-gen-2019 | Giani, Carlotta; Romei, Cristina; Ciampi, Raffaele; Valerio, Laura; Tacito, Alessia; Ramone, Teresa; Materazzi, Gabriele; Torregrossa, Liborio; Ugolini, Clara; Franchi, Alessandro; Basolo, Fulvio; Agate, Laura; Elisei, Rossella | |
| A novel fusion RET/PTC3 involving NCOA4 and RET genes in a pediatric case of Papillary Thyroid Carcinoma | 1-gen-2015 | Ciampi, Raffaele; Romei, Cristina; Tacito, Alessia; Casella, Francesca; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Matrone, Antonio; Vitti, Paolo; Elisei, Rossella | |
| A rare adverse event (AE) in a group of radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients in therapy with lenvatinib. | 1-gen-2019 | Puleo, Luciana; Giani, Carlotta; Valerio, Laura; Viola, David; Molinaro, Eleonora; Elisei, Rossella; Agate, Laura | |
| Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal | 1-gen-2002 | Pacini, F; Molinaro, Eleonora; Castagna, Mg; Lippi, F; Ceccarelli, C; Agate, Laura; Elisei, Rossella; Pinchera, Aldo | |
| Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center | 1-gen-2017 | Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Marcocci, Claudio; Vitti, Paolo; Elisei, Rossella; Molinaro, Eleonora | |
| Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center | 1-gen-2020 | Molinaro, Eleonora; Campopiano, Maria Cristina; Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Cappagli, Virginia; Valerio, Laura; Giani, Carlotta; Puleo, Luciana; Lorusso, Loredana; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Tuttle, R Michael; Elisei, Rossella | |
| Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia | 1-gen-2021 | Prete, A.; Matrone, A.; Gambale, C.; Bottici, V.; Cappagli, V.; Romei, C.; Torregrossa, L.; Valerio, L.; Minaldi, E.; Campopiano, M. C.; Lorusso, L.; Agate, L.; Molinaro, E.; Viola, D.; Ramone, T.; Mule, C.; Ciampi, R.; Basolo, F.; Elisei, R. | |
| Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center. | 1-gen-2013 | D. Viola, L. Valerio; Faviana, Pinuccia; Molinaro, Eleonora; Sensi, Elisa; Agate, Laura; Materazzi, Gabriele; Basolo, Fulvio; Miccoli, Paolo; Vitti, Paolo | |
| All-trans Retinoic Acid treatment inhibits the growth of RARb mRNA expressing thyroid cancer cell lines but does not re-induce the expression of thyroid specific genes | 1-gen-2004 | Agate, Laura; Vivaldi, A; Ciampi, R; Molinaro, Eleonora; Pacini, F; Pinchera, Aldo; Elisei, Rossella | |
| ALL-TRANS RETINOIC ACID TREATMENT INHIBITS THE GROWTH OF RARb mRNA EXPRESSING THYROID CANCER CELL LINES BUT DOES NOT RE-INDUCE THE EXPRESSION OF THYROID SPECIFIC GENES | 1-gen-2005 | Elisei, Rossella; Vivaldi, A; Agate, Laura; Ciampi, R; Molinaro, Eleonora; Piampiani, P; Romei, Cristina; Faviana, Pinuccia; Basolo, Fulvio; Miccoli, Paolo; Capodanno, A; Collecchi, P; Pacini, F; Pinchera, Aldo | |
| Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies | 1-gen-2017 | Molinaro, Eleonora; Romei, Cristina; Biagini, Agnese; Sabini, Elena; Agate, Laura; Mazzeo, Salvatore; Materazzi, Gabriele; SELLARI FRANCESCHINI, Stefano; Ribechini, Alessandro; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella | |
| Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. | 1-gen-2010 | Elisei, Rossella; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Masserini, Lucio; Ceccarelli, C; Lippi, F; Grasso, Lucia; Basolo, Fulvio; Bevilacqua, Generoso; Miccoli, Paolo; Di Coscio, G; Vitti, Paolo; Pacini, F; Pinchera, Aldo | |
| Assessing mPTC Progression during Active Surveillance: Volume or Diameter Increase? | 1-gen-2021 | Campopiano, Maria Cristina; Matrone, Antonio; Rago, Teresa; Scutari, Maria; Prete, Alessandro; Agate, Laura; Piaggi, Paolo; Elisei, Rossella; Molinaro, Eleonora | |
| BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. | 1-gen-2012 | Viola, David; Torregrossa, L; Giannini, Riccardo; Ugolini, C; Bigini, A; Romei, C; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella | |
| Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST | 1-gen-2021 | Lorusso, Loredana; Romei, Cristina; Piaggi, Paolo; Fustini, Chiara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Pellegrini, Giovanni; Elisei, Rossella | |
| Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line | 1-gen-2012 | Vivaldi, Agnese; Ciampi, Raffaele; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P.; Elisei, Rossella | |
| Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line. | 1-gen-2012 | Vivaldi, A; Ciampi, R; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P; Elisei, Rossella |